122 related articles for article (PubMed ID: 38897040)
61. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
[TBL] [Abstract][Full Text] [Related]
62. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.
Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
J Ethnopharmacol; 2010 Jul; 130(2):275-83. PubMed ID: 20457244
[TBL] [Abstract][Full Text] [Related]
63. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
Wen X; Wang JS; Backman JT; Kivistö KT; Neuvonen PJ
Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509
[TBL] [Abstract][Full Text] [Related]
64. Inhibitory effects of trospium chloride on cytochrome P450 enzymes in human liver microsomes.
Beckmann-Knopp S; Rietbrock S; Weyhenmeyer R; Böcker RH; Beckurts KT; Lang W; Fuhr U
Pharmacol Toxicol; 1999 Dec; 85(6):299-304. PubMed ID: 10628907
[TBL] [Abstract][Full Text] [Related]
65. Phytochemical constituents from Scutellaria baicalensis in soluble epoxide hydrolase inhibition: Kinetics and interaction mechanism merged with simulations.
Liu ZB; Sun CP; Xu JX; Morisseau C; Hammock BD; Qiu F
Int J Biol Macromol; 2019 Jul; 133():1187-1193. PubMed ID: 30980876
[TBL] [Abstract][Full Text] [Related]
66. Inhibitory Activity of Quaternary Isoquinoline Alkaloids on Soluble Epoxide Hydrolase.
Kim JH; Cho CW; Hur M; Park WT; Moon YH; Koo SC; Hur YC; Kang JS; Lee IS
Curr Issues Mol Biol; 2022 Sep; 44(9):4282-4289. PubMed ID: 36135206
[TBL] [Abstract][Full Text] [Related]
67. Development of On-line Liquid Chromatography-Biochemical Detection for Soluble Epoxide Hydrolase Inhibitors in Mixtures.
Falck D; Schebb NH; Prihatiningtyas S; Zhang J; Heus F; Morisseau C; Kool J; Hammock BD; Niessen WM
Chromatographia; 2013 Jan; 76(1-2):13-21. PubMed ID: 23526703
[TBL] [Abstract][Full Text] [Related]
68. Screening of soluble epoxide hydrolase inhibitory ingredients from traditional Chinese medicines for anti-inflammatory use.
Liu JY; Morisseau C; Huang H; Hammock BD
J Ethnopharmacol; 2016 Dec; 194():475-482. PubMed ID: 27702689
[TBL] [Abstract][Full Text] [Related]
69. Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4.
Renwick AB; Lewis DF; Fulford S; Surry D; Williams B; Worboys PD; Cai X; Wang RW; Price RJ; Lake BG; Evans DC
Xenobiotica; 2001 Apr; 31(4):187-204. PubMed ID: 11465405
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
[TBL] [Abstract][Full Text] [Related]
71. Inhibition of soluble epoxide hydrolase by phytochemical constituents of the root bark of
Kim JH; Park JS; Lee YJ; Choi S; Kim YH; Yang SY
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1049-1055. PubMed ID: 34000951
[TBL] [Abstract][Full Text] [Related]
72. Protein-Ligand Identification and
Lim SYM; Loo JSE; Alshagga M; Alshawsh MA; Ong CE; Pan Y
Int J Toxicol; 2022; 41(5):355-366. PubMed ID: 35658727
[TBL] [Abstract][Full Text] [Related]
73. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
[TBL] [Abstract][Full Text] [Related]
74. Inhibition of Cytochrome P450s by Strobilanthes crispus Sub-Fraction (F3): Implication for Herb-Drug Interaction.
Yong YF; Liew MWO; Yaacob NS
Eur J Drug Metab Pharmacokinet; 2022 May; 47(3):431-440. PubMed ID: 35146636
[TBL] [Abstract][Full Text] [Related]
75. Structure-activity relationship studies of benzothiazole-phenyl analogs as multi-target ligands to alleviate pain without affecting normal behavior.
Angelia J; Weng X; Solomatov A; Chin C; Fernandez A; Hudson PK; Morisseau C; Hammock BD; Kandasamy R; Pecic S
Prostaglandins Other Lipid Mediat; 2023 Feb; 164():106702. PubMed ID: 36529320
[TBL] [Abstract][Full Text] [Related]
76. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes.
Pang NH; Xu RA; Chen LG; Chen Z; Hu GX; Zhang BW
Toxicol In Vitro; 2024 Mar; 95():105739. PubMed ID: 38042355
[TBL] [Abstract][Full Text] [Related]
77. Synthesis, Docking Study and Biological Evaluation of Amide-Based Soluble Epoxide Hydrolase Inhibitors with Novel Secondary Pharmacophore of Pyrimidin-2-ol.
Hejazi L; Ebadi A; Fakhar Z; Nazari M; Rezaee E; Abbas Tabatabai S
Chem Biodivers; 2022 Nov; 19(11):e202200231. PubMed ID: 36152343
[TBL] [Abstract][Full Text] [Related]
78. Inhibition of cytochrome P450 enzymes by thymoquinone in human liver microsomes.
Albassam AA; Ahad A; Alsultan A; Al-Jenoobi FI
Saudi Pharm J; 2018 Jul; 26(5):673-677. PubMed ID: 29989011
[TBL] [Abstract][Full Text] [Related]
79. An in vitro, high throughput, seven CYP cocktail inhibition assay for the evaluation of new chemical entities using LC-MS/MS.
Otten JN; Hingorani GP; Hartley DP; Kragerud SD; Franklin RB
Drug Metab Lett; 2011 Jan; 5(1):17-24. PubMed ID: 21198441
[TBL] [Abstract][Full Text] [Related]
80. Design, synthesis and biological evaluation of 4-benzamidobenzoic Acid hydrazide derivatives as novel soluble epoxide hydrolase inhibitors.
Rezaee Zavareh E; Hedayati M; Hoghooghi Rad L; Shahhosseini S; Faizi M; Tabatabai SA
Iran J Pharm Res; 2014; 13(Suppl):51-9. PubMed ID: 24711829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
